Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Introductory course in exploratory medicines development, Part II    Back

Association for Applied Human Pharmacology AGAH e.V. in Germany Course Type: Short courses (CPD) Start Date: To be announced
Duration: Full time - 3 Days Fees/total cost: To be announced

Description

This course addresses postgraduates in life sciences interested in early clinical development of medicinal products.
Two training parts of 3 days each (Parts I and II) provide a concise overview on human pharmacology / translational medicine spanning from non‑clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials.
Part II provides an introduction into early / exploratory trials in healthy subjects and patients with a special focus on molecular basis of drug action, pharmacodynamics (endpoints, biomarker), risk assessment and determination of first dose as well as deeper insights in pharmacokinetics. Case studies will be presented and discussed/resolved by the participants in small break out groups. Basic principles of data management, statistical analysis and reporting will be presented. Overview will be given on development of biosimilars.

Learning Outcomes

On successful completion of Part II, students should be able to demonstrate an understanding / knowledge of the following aspects:
- nonclinical pharmacology and toxicology
- molecular basis of drug actions
- allometric scaling and dose proportionality assessments based on characteristic PK data
- defining pharmacodynamic (PD) endpoints and biomarkers
- differentiating between primary and secondary PK and PD endpoints
- method validation according to good clinical (GCP) and good laboratory (GLP) practise
- planning and management of a first-in-man trial
- practical aspects of bioequivalence trials
- principles of data management and information flow
- principles of reporting and publication
- principles of medical statistics
- characteristic issues involved in the development of biologicals and biosimilars

Course contact information

AGAH office
Course Administrator
AGAH e.V.
info@agah.eu
This course meets 9 out of 9 IMI Education & Training shared quality standards ( Show Details)
  • A predefined set of teaching objectives, leading to defined learning outcomes
  • Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
  • A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
  • Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
  • Defined and transparent admission criteria
  • Quality assurance of teaching staff
  • Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
  • The facilities, infrastructure, leadership and competences available for the support of student learning
  • University accreditation OR a system for approving, monitoring and reviewing the training offered
Last update: 14/09/2016
Feedback lifetrain.eu